A prospective, randomized, open comparative study to evaluate safety and efficacy of blue light treatment versus topical benzoyl peroxide 5% formulation in patients with acne grades II and III;Estudo clínico, prospectivo, aberto, randomizado e comparativo para avaliar a segurança e a eficácia da luz azul versus peróxido de benzoíla 5% no tratamento da acne inflamatória graus II e III

Anais Brasileiros de Dermatologia

Volumn 84, Issue 5, 2009, Pages 463-468

  De Arruda, Lúcia H F ^a   Kodani, Vanessa ^a   Bastos Filho, Antonio ^a   Mazzaro, Carla Bassanezi ^b  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^b NONE

Author keywords

Acne vulgaris; Benzoyl peroxide; Phototherapy

Indexed keywords

BENZOYL PEROXIDE;

ACNE VULGARIS; ADOLESCENT; ARTICLE; BLUE LIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PHOTOGRAPHY; PATIENT SAFETY; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCREENING; THERAPY EFFECT;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; PHOTOTHERAPY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 75749089236     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962009000500003     Document Type: Article

References (20)

1. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143-52.
2. Evans DM, Kirk KM, Nyholt DR, Novac C, Martin NG. Teenage acne is influenced by genetics factors. Br J Dermatol. 2005;152:579-81.
3. Bikowski JB. Clinical experience results with clindamicin 1% benzoyl peroxide 5% as monotherapy and in combination. J Drugs. 2005;4:164-71.
4. Dreno B. Topical antibacterial therapy for acne vulgaris. Drugs. 2004;64:2389-97.
5. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292:726-35.
6. Leyden JJ. Therapy for acne vulgaris. N Engl J Med. 1997;336:1156-62.
7. Katsambas A, Papakonstantinou A. Acne: systemic treatment. Clin Dermatol. 2004;22:412-8.
8. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J. 1993;306:55-6.
9. Berg M. Epidemiological studies of the influence of sunlight in the skin. Photodermatol. 1989;6:80-4.
10. Hirsch RJ, Shalita AR. Laser, light and acne. Cutis. 2003;71:353-4.
11. Sigurdsson V, Knulst AC, van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology. 1997;194:256-60.
12. Tzung TY, Wu KH, Huang ML. light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20:266-269.
13. Shalita AR, Harth Y, Elman M. Acne PhotoClearing (APCTM) using a novel, high-Intensity, enhanced, Narrow-band, Blue light source. Clinical Application Notes.
14. Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol. 2000;142:855-6.
15. Papageourgiou P, Katsambas A, Chu A. Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973-8.
16. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is the role? Am J Clin Dermatol. 2004;5:211-6.
17. Ashkenazi H, Harth Y, Malik Z, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. 2003;35:17-24.
18. Futsaether CM, Kjeldstad B, Johnsson A. Intracellular pH changes induced in Propionibacterium acnes by UVA radiation and blue light. J Photochem Photobiol B. 1995;31:125-31.
19. Bussab WO, Morettin PA. Estatística Básica. 4 ed. São Paulo: Atual; 1987.
20. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: Wiley; 1980.